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Individuals differ appreciably and consistently in the magnitude of their inflammatory responses 
to acute stressors. These individual differences in acute stressor-evoked inflammatory responses 
may be one biological mechanism that contributes to heightened risk for cardiovascular disease 
(CVD) and other inflammatory diseases. Critically, the clinical implications and physiological 
origins of these responses remain relatively unexplored. This thesis addresses these questions by 
testing whether magnitude of stressor-evoked interleukin(IL)-6 responses relate to (1) markers of 
cardiovascular disease risk (i.e., systemic inflammation and atherosclerotic CVD risk) or (2) 
stressor-evoked parasympathetic nervous system responses. Participants were 91 healthy midlife 
adults (30-51 years; 33% female; 68% white) who completed a laboratory stress protocol 
consisting of two mental stress tasks: a multisource interference task and Stroop color word task. 
During the protocol, cardiovascular psychophysiological measures were assessed and blood 
samples were drawn after a 30-min baseline and 30-min after task completion. Systemic 
inflammation was indicated by basal levels of C-reactive protein (CRP) and preclinical 
atherosclerotic CVD risk was assessed with intima-media thickness. Parasympathetic nervous 
system activity was measured by high frequency heart rate variability (HF-HRV). Hierarchical 
linear regressions controlling for age, sex, race, and BMI tested whether stressor-evoked IL-6 
responses were associated with basal CRP, intima media thickness, and stressor-evoked HF-
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HRV responses. Ancillary analyses assessed whether these relationships differed by sex. Primary 
analyses indicated that there were no significant associations between stressor-evoked IL-6 
responses and CRP, intima-media thickness, or HF-HRV responses. However, ancillary analyses 
revealed that sex and stressor-evoked IL-6 responses interacted to predict CRP (ΔR2 = .08, B = -
1.33, β = -.39, p = .02); in males, larger stressor-evoked IL-6 responses associated with higher 
CRP while in females, larger stressor-evoked IL-6 responses associated with lower CRP. These 
findings indicate that inflammatory responses to acute stressors associate with resting levels of 
CRP; however, this association differs by sex. Previous literature suggests that there are sex 
differences in stressor-evoked IL-6 responses, but this is the first study to show sex differences in 
the relationship between acute inflammatory responses and systemic inflammation. The 
contribution of these sex differences to inflammatory disease risk warrants further investigation.   
vi 
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PREFACE 
This research was conducted with the help of the members of the Behavioral Neurophysiology 
Laboratory including Sara Snyder, Julie Johnson, Lei Sheu, and Dora Kuan. 
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1.0  INTRODUCTION 
Cardiovascular disease (CVD) is the leading cause of death in the US and other developed 
nations. Inflammation plays a key role in CVD pathophysiology (Libby, Ridker, & Maseri, 2002; 
Ross, 1999). Higher levels of inflammatory markers in peripheral circulation, such as 
interleukin(IL)-6 and C-reactive protein (CRP), predict increased risk for CVD (Danesh et al., 
2008; Danesh et al., 2000). Despite this relationship, the physiological mechanisms underlying 
systemic elevations in circulating inflammatory markers are not entirely clear. Although 
numerous factors contribute to systemic inflammation, there has been increased focus on the role 
of psychological stress. In particular, levels of circulating inflammatory markers increase after 
exposure to acute psychological stress (Rohleder, 2014; Steptoe, Hamer, & Chida, 2007).  
Moreover, the magnitude of these acute stressor-evoked increases varies between individuals 
(Cohen & Hamrick, 2003; Schneiderman et al., 2008). These individual differences in acute 
stressor-evoked inflammatory responses may be one biological mechanism that contributes to 
heightened systemic inflammation and greater CVD risk in general. 
Critically, however, there are major gaps in our knowledge about the extent to which 
stressor-evoked changes in circulating inflammatory markers relate across individuals to (1) 
established measures of CVD risk and (2) known systemic inflammatory predictors of CVD risk 
measured under resting or basal conditions. Until these gaps are addressed, the relationship 
between acute stress-related aspects of systemic inflammation and CVD risk will remain 
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assumed and untested. These gaps in knowledge also extend to the physiological origins of 
stressor-evoked inflammatory responses. Although the physiological origins of inflammatory 
responses are not fully understood, indirect evidence suggests that the parasympathetic nervous 
system (PNS) may regulate stressor-evoked inflammatory responses; however, the relationship 
between PNS and inflammatory responses to stress remains unclear The proposed study thus 
aims to assess the relationship between acute stressor-evoked PNS and inflammatory responses, 
as well as the association between inflammatory responses and two known markers of CVD risk 
(Figure 1). 
Figure 1. Specific Aims 
Aim 1: Test whether acute stressor-evoked inflammatory responses, as measured by 
changes in IL-6, associate positively with resting levels of the circulating inflammatory marker 
CRP, which predicts future CVD.  
Systemic  
Inflammation 
[CRP] 
Atherosclerotic 
CVD Risk 
[IMT] 
Acute Stressor-Evoked 
Inflammatory Response 
[IL-6] 
Acute Stressor-Evoked 
PNS Response 
[HF-HRV] 
Aim 1   
Aim 3 
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Aim 2: Test whether acute stressor-evoked IL-6 responses associate positively with 
preclinical atherosclerosis, as measured by carotid artery intima-media thickness (IMT).  
Aim 3: Test whether larger acute stressor-evoked inflammatory responses (IL-6) 
associate with greater stressor-evoked suppression of PNS activity, as measured by high-
frequency heart rate variability (HF-HRV).  
Aim 4: Test whether greater stressor-evoked suppression of PNS activity (HF-HRV) 
associates with higher resting levels of circulating CRP.  
Ancillary Aim 1: Test for sex differences in the magnitude of stressor-evoked IL-6 
responses. 
Ancillary Aim 2: Test whether the relationship between stressor-evoked IL-6 response 
and CRP varies by sex. 
Ancillary Aim 3: Test whether the relationship between stressor-evoked IL-6 response 
and IMT varies by sex. 
Ancillary Aim 4: Test whether greater stressor-evoked blood pressure responses associate 
with larger stressor-evoked IL-6 responses.  
1.1 CVD AND THE ROLE OF INFLAMMATION 
Inflammation plays a critical role in the pathophysiology of CVD. Long before the onset of 
clinical symptoms, chronic inflammatory processes exacerbate damage to the lining of blood 
vessels and build-up of plaque within arterial walls. These changes are the chief 
pathophysiological basis of CVD: atherosclerosis (Libby et al., 2002; Ross, 1999). 
Atherosclerosis is initiated by damage to the endothelial lining of blood vessels (Ross, 1999). 
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This damage results in an inflammatory response that includes increased permeability of the 
endothelial lining, enabling the migration of lipoproteins and immune cells (e.g., monocytes) into 
the innermost layer of the arterial wall, the intima (Steptoe & Brydon, 2005). Upon entering the 
intima, monocytes mature into macrophages and ingest lipoproteins to become lipid-laden foam 
cells. Macrophages also secrete growth factors and cytokines, proteins that maintain the vascular 
inflammatory response (Ross, 1999; Steptoe & Brydon, 2005). This inflammatory state becomes 
chronic over time, promoting smooth muscle cell migration from the medial layer and 
proliferation in the intima. Over time, this results in the accumulation of cells and waste in the 
intima (Libby, Ridker, & Hansson, 2011; Mitchel & Schoen, 2009). These chronic processes 
occur over many decades and lead to preclinical arterial wall thickening and/or narrowing of the 
lumen, increasing the later risk of clinical CVD (e.g., angina, infarction, etc.) (Eigenbrodt et al., 
2007; Libby et al., 2011). Preclinical atherosclerotic vascular changes can be assessed by 
measuring carotid artery intima-media thickness (IMT), taken to reflect an indirect and 
noninvasive predictor of CVD risk and outcomes (Lorenz, Markus, Bots, Rosvall, & Sitzer, 
2007; Salonen & Salonen, 1993) The degree of preclinical atherosclerotic CVD risk varies 
between individuals in association with biological, behavioral, and psychosocial risk factors 
(Jones, Bromberger, Sutton-Tyrrell, & Matthews, 2003; Matthews, 2005; Sands et al., 2012; 
Thurston et al., 2014; Troxel, Matthews, Bromberger, & Sutton-Tyrrell, 2003). 
The chronic inflammatory state of atherosclerosis involves continuous recruitment of 
immune cells and production of cytokines. Cytokines released by activated macrophages both 
coordinate the local inflammatory response within arterial walls and enter peripheral circulation 
to stimulate a systemic response. This response includes the synthesis and release of acute phase 
proteins, such as CRP and fibrinogen. Levels of these inflammatory markers can be reliably 
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detected in peripheral circulation and are widely assumed to reflect systemic levels of 
inflammation. However, caution should be taken in interpreting these circulating levels as a 
measure of immune-derived processes, as many other cell types produce inflammatory signaling 
proteins, including adipocytes and endothelial cells (Mohamed-Ali et al., 1997; Papanicolaou, 
Wilder, Manolagas, & Chrousos, 1998). For example, adipose tissue is a key source of peripheral 
IL-6, with adipocytes producing 10-35% of circulating levels (Mohamed-Ali et al., 1997).  
Regardless of source, heightened levels of circulating inflammatory mediators confer 
increased CVD risk (Danesh et al., 2008; Danesh et al., 2000) and are suggested as a pathway 
linking stress and CVD risk. Although the majority of evidence describing these pathways 
focuses on circulating inflammatory markers at rest, levels of these markers also rise after 
exposure to acute stressors (Steptoe et al., 2007). The magnitude of acute stressor-evoked 
increases in inflammatory markers may correspond to an individual difference that could relate 
to vulnerability to inflammatory diseases like CVD. As noted, however, the extent to which 
acute stressor-evoked changes in inflammatory markers relate to established predictors of CVD 
risk is unclear. In addition, there are multiple possible physiological origins of these rises in 
circulating inflammatory markers. These issues must be clarified before acute stressor-evoked 
inflammatory responses can be used an indicator of CVD risk. Stressor-evoked changes in 
immune activity are mediated by the autonomic nervous system (ANS) and the hypothalamic-
pituitary-adrenal (HPA) axis, which are detailed in a later section. Described next are the 
stressor-evoked inflammatory changes mediated by these systems.  
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1.2 THE ACUTE STRESOR-EVOKED INFLAMMATORY RESPONSE 
Acute stressor-evoked inflammatory responses are assessed by measuring levels of circulating 
inflammatory markers in the blood before and after exposure to an acute stressor task in the 
laboratory. These tasks typically include elements of time pressure and negative feedback or 
social evaluation and are designed to elicit physiological stress responses (Rohleder, 2014). A 
meta-analytic review of such studies indicates an increase in circulating markers of systemic 
inflammation from pre- to post-task (Steptoe et al., 2007). Although the time course of these 
acute responses is not completely clear, increased circulating levels are typically observed 
around 30-minutes after stressor exposure and last for at least 120 minutes (Brydon, Edwards, 
Mohamed-Ali, & Steptoe, 2004; Carroll et al., 2011; Steptoe et al., 2007). The association 
between acute stressor exposure and increase in circulating markers of inflammation is 
particularly robust for IL-6 and IL-1β, with more studies testing IL-6 (Steptoe et al., 2007). For 
this reason, acute stressor-evoked changes in IL-6 will be of primary interest in the present study. 
Laboratory studies show that individuals differ consistently in the magnitude of their 
immune responses to acute stress, with some individuals showing large responses across 
occasions of testing and others little or no response (Black, 2003; Marsland, Bachen, Cohen, 
Rabin, & Manuck, 2002; Marsland, Manuck, Fazzari, Stewart, & Rabin, 1995). Larger acute 
stressor-evoked inflammatory responses may indicate a tendency toward greater inflammatory 
responses in general, or a “proinflammatory phenotype”. This proinflammatory phenotype may 
increase vulnerability to inflammatory diseases like atherosclerosis (Miller et al., 2011). Thus, to 
the extent that larger acute stressor-evoked inflammatory responses are stable attributes of 
individuals that characterize responses to frustrations in daily life, they may relate to 
vulnerability to inflammatory diseases. To date, only two studies have considered this 
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possibility. These studies, drawn from the same cohort, reported that acute stressor-evoked 
inflammatory responses predict carotid artery stiffness and ambulatory blood pressure at a 3-year 
follow-up, suggesting that there may be a relationship between this individual difference and 
future CVD risk (Brydon & Steptoe, 2005; Ellins et al., 2008). The present study will conduct an 
initial examination of whether magnitude of IL-6 response is associated with two additional 
CVD risk factors: resting levels of circulating inflammatory markers and atherosclerotic CVD 
risk. 
Heightened resting levels of circulating inflammatory markers, particularly CRP, are 
associated with increased risk for CVD (Kaptoge et al., 2010; Libby & Ridker, 1999; van Holten 
et al., 2013). However, it is unknown whether individuals who show greater stressor-evoked 
inflammatory responses are at increased risk for elevated resting levels of CRP and thus CVD. 
Accordingly, this study aims to determine whether the magnitude of an individual’s acute 
stressor-evoked IL-6 response is associated with circulating levels of CRP (Aim 1). Based on 
previous reports of sex differences in stressor-evoked IL-6 responses (Edwards, Burns, Ring, & 
Carroll, 2006; Hackett, Hamer, Endrighi, Brydon, & Steptoe, 2012; Steptoe, Owen, Kunz-
Ebrecht, & Mohamed-Ali, 2002), ancillary analyses will also test whether the magnitude of IL-6 
response differs by sex (Ancillary Aim 1) and whether the association between IL-6 response 
and CRP varies by sex (Ancillary Aim 2). 
Given the pathogenic role of inflammation in atherosclerosis, it is possible that acute 
stressor-evoked rises in circulating inflammatory markers are linked with atherosclerotic CVD 
risk. This link has a number of theoretical explanations. One possibility is the previously 
discussed proinflammatory phenotype model (Miller et al., 2011). An alternative explanation is 
that heightened levels of circulating inflammatory markers play a causal role in atherosclerosis 
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by exacerbating ongoing local atherosclerotic inflammatory processes. This explanation is 
supported by prospective findings linking elevated systemic inflammation to later CVD 
incidence (Ridker, Rifai, Stampfer, & Hennekens, 2000). Although the proposed study will not 
test how stressor-evoked inflammatory responses relate to a clinical outcome, it will provide an 
initial test of the possibility that individual differences in the magnitude of inflammatory 
reactivity associate with IMT, a preclinical marker of atherosclerotic risk (Aim 2). Ancillary 
analyses will assess sex differences in the association between stressor-evoked IL-6 responses 
and IMT (Ancillary Aim 3). 
1.3 OVERVIEW OF RELATED PHYSIOLOGICAL SYSTEMS 
Gaps in current knowledge of stressor-evoked IL-6 responses also extend to mechanistic control 
of these responses. These responses are thought to be controlled by activation of two pathways 
that link the central nervous and immune systems: the ANS and the HPA axis. Both of these 
pathways respond to acute psychological stress and may thus contribute to stress-induced 
inflammatory responses.  
The ANS regulates physiological processes required for responding to stressors and 
maintaining homeostasis. Its two primary divisions are the parasympathetic nervous system 
(PNS) and the sympathetic nervous system (SNS). Each division innervates many different 
organs and regulate a wide variety of physiological functions outside of conscious control, 
including immune function (Kemeny, 2011). There are a number of methods of assessing both 
PNS and SNS activity, such as pharmacological blockade of receptors specific to each system 
and direct nerve recording or stimulation. Psychophysiological methods have also been used to 
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indirectly assess ANS activity, providing a relatively noninvasive way to examine the activity of 
these two systems in humans (Berntson et al., 1997; Sherwood et al., 1990; Task Force, 1996).  
Heart rate variability (HRV) is one cardiovascular psychophysiological measure that 
indirectly assesses ANS activity. HRV is the fluctuation of time between consecutive heartbeats 
and is influenced by both SNS and PNS input to the heart. PNS activity is thought to be reflected 
by high-frequency variation in HRV (HF-HRV). HF-HRV refers to changes in the heart period 
that occur within 9-24 cycles per minute, a frequency band correlated with respiratory frequency. 
Notably, HF-HRV is closely related to a similar marker of PNS activity known as respiratory 
sinus arrhythmia (RSA) (Berntson et al., 1997). Although HF-HRV and RSA use different 
quantification methods, they are highly correlated and derived with a similar theoretical 
framework (Berntson et al., 1997; Task Force, 1996). Strong evidence from pharmacological 
blockade studies suggests that HF-HRV is almost exclusively influenced by PNS input to the 
heart. Specifically, administration of PNS antagonists leads to near complete elimination of HF-
HRV (Berntson et al., 1997). Measures of HF-HRV are sensitive to acute psychological stress; a 
recent meta-analysis found that HF-HRV and two other measures of PNS input to the heart 
decrease during acute laboratory stressors (Brindle et al., 2014). This finding suggests that acute 
stress evokes withdrawal of PNS input to the heart. It should be noted that HF-HRV is useful for 
noninvasively assessing PNS input to the heart but it does not necessarily reflect PNS input to 
the rest of the body; thus, the inferences we can make with this measure are limited. 
The activity of the SNS can also be measured indirectly by cardiovascular 
psychophysiological methods, but these measures were not assessed in the present study. Blood 
pressure (BP) measures are available as a gross indicator of SNS outflow to the heart and 
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vasculature and will be used in ancillary analyses. Specifically, these analyses will test whether 
stressor-evoked BP is significantly associated with stressor-evoked IL-6 (Ancillary Aim 4). 
Similar to the ANS, the HPA axis response can also be triggered by stress. This response 
is initiated by the hypothalamus, which stimulates release of adrenocorticotropic hormone 
(ACTH) from the pituitary gland into peripheral circulation. ACTH travels to the adrenal cortex, 
where it stimulates secretion of glucocorticoids (GCs) (Cacioppo & Berntson, 2011). GCs have a 
number of essential functions, including regulation of immune response. Cortisol, one commonly 
studied GC, typically rises after acute stress, though this response may be down-regulated upon 
exposure to chronic stress (Miller, Cohen, & Ritchey, 2002). 
1.4 MECHANISTIC BASIS OF IL-6 RESPONSES 
Stressor-evoked inflammatory responses are mediated by the ANS and the HPA axis, however, 
the specific mechanisms that drive these changes are not entirely clear. To date, there has been 
an emphasis on the role of the SNS and the HPA axis in driving these responses. Although it has 
been suggested that acute stressor-evoked IL-6 responses and PNS activity during stress might 
be related, this association remains largely unexplored. Thus, the PNS will be the primary focus 
of the present study. The SNS and HPA axis literature will be briefly reviewed to put the 
emerging PNS literature into context.  
Previous work suggests that the acute stressor-evoked inflammatory response parallels 
and may be predicted by stress-related activation of the SNS. A series of rodent studies showed 
that sympathetic catecholamines play an important role in stress-induced IL-6 changes (Johnson 
et al., 2005). Specifically, pharmacological blockade of α- and β-adrenergic receptors attenuated 
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IL-6 increases in rats exposed to acute stress compared with controls. In another experiment, 
injection of a β-adrenergic receptor agonist elevated circulating IL-6 levels after 60 minutes 
(Johnson et al., 2005). These findings suggest that stressor-evoked increases in catecholamines 
may trigger IL-6 production. 
Direct human evidence for this mechanism is limited. In line with rodent findings, 
healthy adults show a significant association between norepinephrine (NE) and IL-6 responses to 
acute stress (Kop et al., 2008). Additionally, in vitro evidence supports increased activation of 
nuclear factor κB (NF-κB), a transcription factor that triggers IL-6 production, when peripheral 
blood mononuclear cells are treated with NE (Bierhaus et al., 2003). However, one study 
indicated that administration of a β-adrenergic antagonist does not attenuate stressor-evoked IL-6 
responses in healthy adults (von Kanel et al., 2008), though this discrepancy may be due to drug 
timing (Rohleder, 2014). Given that NE release is triggered by SNS response to acute stress, 
these findings suggest that SNS activation is involved in acute stressor-evoked IL-6 responses. 
In addition to the SNS, it is likely that the HPA axis plays a role in regulating the acute 
stressor-evoked inflammatory response. The HPA-axis secretes GCs in response to psychosocial 
stress, which typically inhibit the production of IL-6 and other proinflammatory cytokines. In 
addition, cytokines can activate the HPA-axis, creating a feedback loop that regulates stressor-
evoked inflammatory responses (Darnall & Suarez, 2009; Miller et al., 2002). Indeed, there is an 
inverse association between cortisol and IL-6 responses to acute stress (Rohleder, 2014) and 
between NF-κB and cortisol responses to acute stress (Wolf, Rohleder, Bierhaus, Nawroth, & 
Kirschbaum, 2009). These findings suggest that the HPA axis may also play a key role in 
regulating acute stressor-evoked inflammatory responses. 
Comparatively less is known about the role of the PNS in the regulation of the acute 
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stressor-evoked IL-6 response. There is, however, evidence that the PNS plays a tonic inhibitory 
role in regulating inflammation. This work is summarized by Tracey’s (2002) characterization of 
the cholinergic anti-inflammatory pathway. According to this pathway, tonic stimulation of the 
vagus nerve promotes the release of acetylcholine (ACh), the primary neurotransmitter of the 
PNS. ACh has an anti-inflammatory effect, down-regulating macrophage production of 
proinflammatory cytokines. Through this pathway, tonic PNS activity prevents the 
overproduction of cytokines and protects the body from the harmful effects of excessive 
inflammation (Tracey, 2002). 
The cholinergic anti-inflammatory pathway is supported by experimental evidence 
(Tracey, 2009). To summarize, in vitro evidence shows that ACh inhibits stimulated cytokine 
production (Borovikova et al., 2000). Rodent evidence also shows that electrical stimulation of 
the vagus nerve attenuates cytokine synthesis by immune cells (Borovikova et al., 2000). 
Additionally, vagotomy leads to exaggerated stimulated cytokine production and tissue damage 
(Schulte, Lichtenstern, Henrich, Weigand, & Uhle, 2014). Although it remains to be shown that 
the vagus nerve innervates primary immune organs in humans (Nance & Sanders, 2007), there is 
evidence that the PNS plays a role in down-regulating the inflammatory response. Indeed, human 
psychophysiological evidence shows inverse associations of circulating levels of IL-6 and CRP 
with resting HF-HRV (Sloan et al., 2007). Lower resting HF-HRV has also been linked with 
greater stimulated production of cytokines, including IL-6, in response to an in vitro 
inflammatory challenge (Marsland et al., 2007). These findings are consistent with a cholinergic 
anti-inflammatory pathway, indicating that lower levels of tonic PNS activity may relate to 
heightened inflammatory responses and higher resting levels of inflammatory markers.  
The current psychophysiological evidence linking PNS activity and inflammatory 
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markers has primarily focused on resting levels of HF-HRV. As the cholinergic anti-
inflammatory pathway proposes that the PNS regulates inflammatory responses in real time, it is 
possible that acute stressor-evoked changes in PNS activity may also regulate circulating 
inflammatory markers. It is unknown, however, whether there is an association between acute 
stressor-evoked changes in PNS activity and IL-6 responses or background levels of systemic 
inflammation. One study found that IL-6 responses to stress were not associated with either 
baseline or task levels of PNS driven HRV (Owen & Steptoe, 2003). Other than this null result, 
the association of stressor-evoked HF-HRV with resting and stressor-evoked inflammatory 
markers remains unexplored. Thus, a goal of the present study is to determine whether acute 
stressor-evoked decreases in HF-HRV are associated with the magnitude of acute stressor-
evoked IL-6 response (Aim 3) or resting levels of CRP (Aim 4). 
1.5 SCOPE OF THE PROPOSED STUDY 
Although inflammatory processes play a key role in CVD pathophysiology, this relationship is 
primarily assessed using basal circulating levels of inflammatory markers thought to reflect 
sustained levels of systemic inflammation. Levels of circulating inflammatory markers increase 
in response to acute stress, but key information is unknown about these responses. These gaps in 
knowledge prevent key inferences about the relevance of stressor-evoked inflammatory 
responses for CVD risk.  
First, the relationship between these acute stressor-evoked inflammatory responses and 
established CVD risk factors remains largely unstudied. The present study will address this by 
assessing the relationship between acute stressor-evoked IL-6 responses and two established 
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predictors of CVD: IMT and CRP. We hypothesize that larger acute stressor-evoked IL-6 
responses will be associated with higher levels of resting CRP, a relatively stable marker of 
inflammation and established risk factor for CVD (Hypothesis 1). Additionally, we hypothesize 
that larger acute stressor-evoked IL-6 responses will be associated with greater IMT, a measure 
of preclinical atherosclerotic CVD risk (Hypothesis 2).  
The specific physiological mechanisms that underlie acute stressor-evoked IL-6 
responses are also unclear. Current research suggests that the SNS and HPA axis play a role in 
driving and regulating these responses, but little is known about the association between stressor-
evoked PNS responses and circulating inflammatory markers. The current study addresses this in 
two ways: examining the association between acute stressor-evoked PNS changes and 1) 
stressor-evoked IL-6 changes, and 2) circulating levels of CRP. We hypothesize that greater 
decreases in HF-HRV during stress will be associated with larger IL-6 responses (Hypothesis 3) 
and higher levels of CRP (Hypothesis 4). These relationships will be examined in healthy midlife 
adults who participated in a laboratory study on the physiological correlates of stress and CVD.  
 15 
2.0  RESEARCH DESIGN AND METHODS 
2.1 PARTICIPANTS 
Participants were 91 adults from the Pittsburgh Imaging Project Phase II (PIP II), a study of 176 
healthy volunteers residing in Allegheny County, Pennsylvania. This subsample completed a 
separate protocol to assess physiological and inflammatory responses to laboratory stressors. 
Participants were between the ages of 30-51 and recruited through mass mail solicitations. Two 
participants were excluded from the analytic sample due to high IL-6 (see Analytic Plan). 
Descriptive statistics were assessed for the 89 remaining participants (Table 1). The sample 
included 53 males and 36 females; this imbalance was due to the fact that only males were 
recruited for PIP II study during the second half of data acquisition. The majority of participants 
identified as White (68.5%) and 25.8% identified as Black. For analytic purposes, the 5 
participants who did not identify as White or Black were grouped with Black participants for 
analyses. Average annual family income was $61,119, although there was a sizable range (SD = 
$44,245). A large proportion of participants had completed college (52.3%) or graduate 
education (33.3%). The sample was slightly overweight, with a mean BMI of 26.10. The 
majority of participants had never smoked (72.2%). CRP levels were low (M = 0.20mg/dL) and 
IMT was average for this age group (M = 0.60mm) (Lorenz et al., 2007; O’Leary & Bots, 2010). 
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Table 1. Descriptive Statistics 
Mean or n SD or % N 
Age (years) 40.12 6.61 89 
Sex (female) 36 40.4% 89 
Race 89 
    White 61 68.5% 
    Black 23 25.8% 
    Asian 4 4.5% 
    Multiracial 1 1.1% 
BMI (kg/m2) 26.1 4.63 89 
Smoking Status 89 
    Never 64 72.2% 
    Former 10 11.1% 
    Current 15 16.7% 
Education 89 
    High School 13 14.4% 
    College 46 52.3% 
    Graduate  30 33.3% 
Annual family income $61,119 $44,245 87 
Baseline IL-6 (pg/mL) 1.22 0.92 62 
Baseline HF-HRV (ln) 5.63 1.22 84 
CRP (mg/dL) 0.20 0.27 80 
IMT (mean of average; mm) 0.60 0.08 89 
Exclusion criteria for the study included: history of cardiovascular disease (including 
hypertension); prior cardiovascular or cerebrovascular surgery; chronic kidney or liver 
conditions; Type I or II diabetes; any pulmonary or respiratory diseases; current diagnoses of a 
substance abuse or mood disorder; and use of any cardiovascular, psychotropic, or lipid lowering 
medications. This study had a magnetic resonance imaging component and thus excluded 
participants with: history of neurosurgery or a neurological condition; head trauma leading to 
loss of consciousness; pregnancy; and claustrophobia or metallic implants. Data collection took 
place over multiple sessions (Figure 2) and informed consent procedures were carried out 
following guidelines of the University of Pittsburgh Institutional Review Board. 
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Figure 2. PIP study protocol and measures 
 
2.2 PROCEDURES 
Acute stressor-evoked inflammatory response data were collected during a laboratory session 
that began between 12:00 and 1:00 PM. Participants were instructed to abstain from caffeine (12 
hours), strenuous physical activity (24 hours), non-prescription medications (24 hours), and 
alcohol (48 hours) before the session. On arrival, participants completed an acute illness-
screening questionnaire; to avoid heightened inflammation due to acute illness, those with cold 
Visit 1: IMT  
Visit 2: fMRI 
Visit 3: Lab Stress 
4-6 Weeks 
1-2 Weeks 
Carotid ultrasound (IMT) 
Demographic questionnaires 
Fasting blood sample (CRP) 
Anthropometric measures (BMI) 
Smoking habits questionnaire 
Acute stressor-evoked IL-6 
Acute stressor-evoked HF-HRV 
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or flu symptoms within 48 hours were rescheduled. Next, participants were prepared for 
electrocardiogram (EKG), respiration, and BP assessment. An intravenous catheter was then 
inserted into the antecubital vein of the left arm for the collection of blood samples. Participants 
then rested quietly for a 30-min baseline period, after which the first blood sample was drawn. 
After the baseline, participants performed two stressor tasks, separated by a 4-min rest period. 
Participants then rested quietly for a 30-min recovery period. The post-stressor blood sample was 
collected 30-min after completion of the second stressor task. EKG, respiration, and BP 
measurements were collected during the last 10 minutes of the baseline period, throughout both 
tasks, and during the first 10 minutes of the recovery period.  
Participants completed two standardized mental stress tasks validated for laboratory 
studies of stress reactivity: a Stroop color-word task and the multi-source interference task 
(MSIT) (Gianaros et al., 2009; Kamarck et al., 1992). Both tasks have elements of conflict, time 
pressure, error feedback, and uncontrollability. Each task included alternating difficult 
(incongruent) and easy (congruent) conditions. In the Stroop task, participants saw one target 
word and four identifier words and instructed to identify the color of the target word by selecting 
the correct identifying word. In the MSIT task, participants saw with three numbers and 
instructed to select the number that is different from the other two numbers. To increase task 
difficulty during incongruent trials, a loud voice stated a random answer choice; the voice stated 
the correct answer during congruent trials. During each task, incorrect or delayed responses 
elicited automated negative feedback. Each task lasted approximately 9 minutes with adaptive 
inter-trial intervals so that accuracy was titrated to <60% for all participants (for further detail, 
see Sheu, Jennings, & Gianaros, 2012). These tasks have been shown to reliably elicit 
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cardiovascular responses in a comparable sample, with intra-class correlation coefficients of 
0.75-0.85 (Sheu, Jennings, & Gianaros, 2012). Task order was randomized across participants. 
2.3 MEASURES 
Participants self-reported age, sex, race, education, and family income on a standard 
demographics questionnaire. 
Baseline and 30-min post-task blood samples were used to assess circulating levels of IL-
6. Immediately after each blood draw, whole blood was centrifuged at room temperature at 2500 
rpm for 10 minutes and plasma was removed and stored at -80 degrees Celsius. Plasma IL-6 
levels were determined using high sensitivity ELISA kits (R&D Systems, Minneapolis). Samples 
were run in duplicate and average intra-assay coefficients of variation for Baseline and 30-min 
post-task were 4% and 5%, respectively. The two samples from each participant were run on the 
same plate. There were 27 participants who did not provide blood samples due to refusal to 
undergo intravenous catheterization (N=9) or blood sampling problems (N=18). There were no 
statistically significant differences in age, sex, or BMI between participants who completed the 
blood draw and those who did not. These participants were not included any IL-6 analyses. 
Resting levels of high-sensitivity CRP (mg/dL) were measured from a fasting blood 
sample taken during Visit 2. CRP was assayed by a CRPH reagent on a SYNCHRON LX 
System (Beckman Coulter, Inc.) in the Clinical Services Laboratory of the Western Psychiatric 
Institute and Clinic. CRP levels are stable across relatively long periods (1-5 years) (Ridker, 
2007). As no participants had CRP levels indicating acute illness ( >10 mg/L), all participants 
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with CRP data were included in analyses. There were ten participants who did not have CRP 
values due to blood sampling issues. These participants were not included in CRP analyses. 
Preclinical atherosclerotic risk was indexed by carotid artery IMT, assessed during Visit 
1 of the study. Specifically, IMT was measured as the mean IMT of the carotid vessel wall 
complex (Sutton-Tyrrell, Wolfson, Thompson, & Kelsey, 1992; Thompson, Sutton-Tyrrell, & 
Wildman, 2001). This measure has been used as both an indicator of preclinical atherosclerosis 
and a surrogate marker of coronary atherosclerosis (Craven et al., 1990; Probstfield et al., 1993). 
IMT was assessed by B-mode ultrasonography by a vascular technologist using an Acuson 
Antares scanner (Acuson-Simens, Malvern, Pennsylvania) and averaged across the common, 
bulb, and internal carotid artery segments. These values are determined using automated edge 
detecting scoring software (Artery Measurement System, Gothenburg, Sweden) (Wendelhag, 
Liang, Gustavsson, & Wikstrand, 1997). IMT assessments were carried out at the Epidemiology 
Ultrasound Research Laboratory at University of Pittsburgh. 
HRV was derived from continuous EKG assessment during the laboratory stress protocol. 
A modified lead II electrode placement using three electrodes was used and EKG was sampled at 
1000 Hz using MindWare software (Mindware Technologies, Gahanna, OH). Prior to calculating 
HRV estimates, EKG signals were inspected for irregularities and artifactual R-waves were 
corrected. Spectral analysis was used to determine the high frequency portion of HRV (HF-
HRV) using a bandwidth of 0.15-0.40 Hz. Procedures and analyses were conducted in 
accordance with published guidelines (Task Force, 1996). Of the participants who completed the 
laboratory protocol, six participants did not have usable HF-HRV data due to equipment issues 
(N=5) or arrhythmia (N=1). HR and respiration rate were also collected during the laboratory 
stress protocol, given their known relationships with HF-HRV (Berntson et al., 1997). HR was 
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measured using the continuous EKG assessment described above. Respiration rate was assessed 
using a Sleepmate Piezo effort sensor belt and processed using Mindware analysis software. 
Systolic (SBP) and diastolic (DBP) BP were assessed oscillometrically by a Dinamap Automated 
Blood Pressure Monitor Model V100. BP readings were taken at 2-minute intervals during the 
rest periods and 1-minute intervals during the tasks. 
Smoking status and BMI were measured and included as covariates, given their 
associations with systemic inflammation (O'Connor et al., 2009). Smoking status was measured 
via self-report of smoking habits and history. BMI was determined using participants’ height and 
weight measurements and calculated as weight (kg)/height (m2). 
2.4 ANALYTIC PLAN 
Analyses were carried out using SPSS. Resting CRP, Baseline and 30-min post-task IL-6, and 
HF-HRV values were non-normally distributed and were log transformed prior to analyses. A 
log-10 transformation was used for CRP, and natural log transformations were used for IL-6 and 
HF-HRV. Preliminary descriptive analyses revealed one participant with a circulating baseline 
IL-6 level of 11.33pg/mL and another with a raw IL-6 change of 4.95pg/mL; as these values 
deviated substantially (>6 SD) from the means for Baseline IL-6 and IL-6 change scores, these 
two participants were not included in analyses. No other outliers were detected for primary 
variables. HF-HRV, HR, respiration rate, and BP values were averaged over each period to give 
a single value for each of the following periods: Baseline, MSIT Incongruent, MSIT Congruent, 
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Stroop Incongruent, Stroop Congruent, and Recovery. These values were then averaged across 
the two stressor tasks, resulting in two task variables: Incongruent and Congruent1.  
Stressor task effects were assessed for IL-6, HF-HRV, HR, and respiration rate. A paired 
samples t-test was used to test for a significant difference in IL-6 from Baseline to 30-min post 
task. Repeated measures ANOVAs were used to determine main effects of the stressor tasks on 
psychophysiological measures. Greenhouse-Geisser corrections were applied when the sphericity 
assumption was violated. Planned contrasts tested whether mean values for Incongruent, 
Congruent, and Recovery periods differed significantly from Baseline.  
Hierarchical linear regressions tested primary study hypotheses. Residualized change 
scores were created for IL-6 and HF-HRV. IL-6 change scores were computed by regressing 30-
min post-task IL-6 levels on Baseline IL-6 levels. HF-HRV change scores were created by 
regressing Incongruent HF-HRV values on Baseline HF-HRV values. Age, sex, race, smoking 
status, and BMI were used as covariates. Dummy coding was used for sex (0 = male, 1 = 
female) and smoking status (0 = never, 1 = former, 2 = current). Each aim was tested with two 
regression models: 1) a minimally adjusted model with age, sex, and race on Step 1 and 2) a fully 
adjusted model with age, sex, and race on the Step 1 and BMI and smoking status on Step 2. 
To test whether acute stressor-evoked IL-6 changes associate positively with resting 
levels of CRP (Aim 1), regression models predicting CRP with residualized IL-6 change scores 
                                                 
1 Two additional methods of combining the physiological variables during the laboratory session were also 
considered: 1) combining task levels across Incongruent and Congruent segments, resulting in separate MSIT and 
Stroop variables and 2) combining across tasks and across Incongruent and Congruent segments, resulting in a 
single variable. Regardless of the method, all ANOVA and regression analyses followed a similar pattern of results. 
 23 
were conducted. This analysis included 572; 33 participants in the analytic sample were not 
included due to missing IL-6 data (N=23), missing CRP data (N=6), or missing both (N=4). 
To test whether acute stressor-evoked IL-6 changes associate positively with IMT (Aim 
2), regression models predicting IMT with residualized IL-6 change scores were conducted. This 
analysis included 62 participants3; 27 participants were excluded due to missing IL-6 data. 
To test if larger stressor-evoked IL-6 changes associate with greater stressor-evoked HF-
HRV suppression (Aim 3), regression models predicting residualized IL-6 change scores with 
residualized HF-HRV change scores were conducted. This analysis included 57 participants4; 32 
participants were not included due to missing IL-6 (N=26), HF-HRV (N=5), or both (N=1).  
To test whether greater stressor-evoked suppression of HF-HRV associates with higher 
resting levels of CRP (Aim 4), regression models predicting CRP with residualized HF-HRV 
change scores were conducted. This analysis included 76 participants5; 14 participants were not 
included due to missing HF-HRV data (N=4), CRP data (N=8), or both (N=2).  
Ancillary analyses focused on sex differences tested three questions. First, are there sex 
differences in the magnitude of IL-6 responses (Ancillary Aim 1)? This question was tested 
using a repeated measures ANOVA, with sex as a between-subjects factor. 
Second, does the relationship between stressor-evoked IL-6 response and CRP vary by 
sex (Ancillary Aim 2)? This question was tested with two regression models, one minimal model 
                                                 
2The Aim 1 subsample was not significantly different from the rest of the analytic sample on age, sex, race, BMI, 
smoking status, years of schooling, or resting CRP. 
3The Aim 2 subsample was not significantly different from the rest of the analytic sample on age, race, BMI, 
smoking status, years of schooling, or mean IMT. There were fewer females in the subsample compared with the 
overall sample (Χ2 = 5.51, p = .034).  
4 The Aim 3 subsample was not significantly different from the rest of the analytic sample on age, race, BMI, 
smoking status, years of schooling, or baseline HF-HRV. There were fewer females in the subsample compared with 
the analytic sample (Χ2 = 5.34, p = .032). 
5 The Aim 4 subsample was not significantly different from the rest of the analytic sample on age, sex, race, BMI, 
smoking status, years of schooling, resting CRP, or baseline HF-HRV. 
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and one fully adjusted. The minimal model included sex and residualized IL-6 change scores on 
Step 1 and a “sex x IL-6 change” interaction term on Step 2. The fully adjusted model included 
sex and residualized IL-6 change scores on Step 1, covariates (age, BMI, race, and smoking 
status) on Step 2, and the sex x IL-6 change interaction term on Step 3. All continuous variables 
were mean centered prior to regression analyses. 
Third, does the relationship between stressor-evoked IL-6 response and IMT vary by sex 
(Ancillary Aim 3)? This question was tested using the same method as described for Ancillary 
Aim 2, using IMT as the outcome variable in place of CRP.  
Ancillary analyses also assessed whether there were significant associations between 
stressor-evoked SBP and/or DBP responses and stressor-evoked IL-6 responses (Ancillary Aim 
4). BP data reduction was carried out using the same process as was used for the EKG derived 
psychophysiological measures: mean SBP and DBP values were calculated for Baseline, 
Incongruent, Congruent, and Recovery. A preliminary repeated measures ANOVA tested 
whether there was a significant main effect of the stressor tasks on SBP and DBP.  Finally, 
separate regression models were used to assess the association between stressor-evoked IL-6 
responses and both SBP and DBP responses. Residualized BP change scores were created by 
regressing SBP and DBP levels during the Incongruent period on levels during the Baseline 
period. In the regression models, residualized BP change scores were entered as independent 
variables. Each association was tested using a minimally adjusted model and a fully adjusted 
model. As in primary analyses, the minimally adjusted models contained age, sex, and race on 
Step 1, with BMI and smoking status added in a second step in the full model. 
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3.0  RESULTS 
3.1 BIVARIATE CORRELATIONS 
There were a number of significant correlations between primary variables (Table 2). Older age 
was significantly correlated with lower Baseline HF-HRV (r = -.39, p < .001) and greater IMT (r 
= .45, p < .001). In addition, higher BMI was significantly correlated with higher Baseline IL-6 
(r = .39, p=.001) and lower HF-HRV (r = -.22, p = .04). Higher BMI was also significantly 
correlated with higher CRP (r = .36, p = .001) and greater IMT (r = .30, p = .004). There was 
also a trend toward a positive association between Baseline IL-6 and resting CRP (r = .23, p = 
.08). Stressor-evoked IL-6 and HF-HRV change scores were not significantly correlated with any 
primary study variables. 
 
Table 2. Bivariate Correlations 
  1 2 3 4 5 6 7 8 
1. Age (years) - 
       2. BMI (kg/m2) .18 - 
      3. IL-6 Baseline .04 .39** - 
     4. IL-6 Change .03 -.05 .01 - 
    5. HF-HRV Baseline .39*** -.22* .03 -.04 - 
   6. HF-HRV Change -.10 -.02 -.21 -.14 .00 - 
  7. CRP (mg/dL) -.07 .36** .23 .15 -.15 -.11 - 
 8. IMT (mm) .45*** .30** .18 .12 -.15 -.01 -.02 - 
Note: *** p < .001, ** p < .01, * p < .05 
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3.2 STRESSOR TASK EFFECTS 
Mean values for IL-6, HF-HRV, HR, and respiration rate varied across the different task periods 
(Table 3; Figure 3-6). Circulating IL-6 increased significantly from Baseline to 30-min post-task 
(t (61) = -4.83, p < .001). There was a significant main effect of the stressor tasks on HF-HRV 
(F(2.74, 227.23) = 54.06, p <.001, ηp  = .59).  HF-HRV decreased significantly from Baseline to 
both Incongruent (F(1, 83) = 91.65, p <.001, ηp  = .53) and Congruent (F(1, 83) = 55.81, p < 
.001, ηp  = .40), but not from Baseline and Recovery (F(1, 83) = 1.28, p = .26, ηp  = .02). There 
was also a significant main effect of the stressor tasks on HR (F(2.28, 188.93) = 24.50, p <.001, 
ηp  = .23). HR increased significantly from Baseline to Incongruent (F(1, 83) = 37.51, p < .001, 
ηp  = .31) and Congruent (F(1, 83) = 7.50, p = .008, ηp  = .08), but not from Baseline to 
Recovery (F(1, 83) = .20, p = .66, ηp  = .002). Finally, there was a significant main effect of the 
stressor tasks on respiration rate (F(2.43, 201.97) = 65.59, p <.001, ηp  = .441). Respiration 
increased significantly from Baseline to Incongruent (F(1, 83) = 91.76, p < .001, ηp  = .53) and 
Congruent (F(1, 83) = 51.09, p < .001, ηp  = .38) but not from Baseline to Recovery (F(1, 83) = 
3.95, p = .05, ηp  = .05).  
Table 3. Mean HR, HF-HRV, respiration rate, and IL-6 values across the testing session 
Baseline Incongruent Congruent Recovery 30-min post 
IL-6  1.22 (0.92) - - - 1.36 (0.96) 
HF-HRV 5.64 (1.21) 4.97 (1.15) 5.23 (1.27) 5.58 (1.12) - 
HR 71.9 (11.70) 74.57 (11.73) 72.83 (11.37) 72.08 (10.99) - 
Respiration  15.83 (2.75) 18.94 (3.81) 17.51 (3.60) 15.30 (3.11) - 
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Figure 3. Effect of the acute stressor tasks on IL-6 
 
 
 
 
Figure 4. Effect of the acute stressor tasks on HF-HRV 
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Figure 5. Effect of the acute stressor tasks on HR 
 
 
 
Figure 6. Effect of the acute stressor tasks on respiration rate 
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3.3 PRIMARY AIMS 
The hypothesis that larger stressor-evoked IL-6 responses are associated with higher levels of 
CRP (Aim 1) was not supported. Stressor-evoked IL-6 change scores were not significantly 
associated with CRP in the minimally adjusted model (β = .19, p = .17) or the fully adjusted 
model (Table 4). In the fully adjusted model, demographic variables (Step 1) did not predict 
significant variance in CRP. BMI and smoking status (Step 2) accounted for 17% of the variance 
in CRP (ΔR2 = .17, p = .007), largely driven by the positive association between BMI and CRP 
(β = .37, p = .01). Stressor-evoked IL-6 responses (Step 3) showed a trend-level association with 
CRP (β = .22, p = .09) (Figure 7).  
 
Table 4. Aim 1: Linear regression predicting CRP with stressor-evoked IL-6 
  N = 57   
  B SE β p R2 ΔR2 ΔF Sig. ΔF 
Step 1 
    
.04 .04 .82 .49 
  Age -.01 .01 -.07 .63 
      Sex .02 .12 -.02 .87 
      Race  .15 .12 .18 .21 
    Step 2  
    
.21 .17 5.41 .007 
  BMI .03 .01 .37 .01 
      Smoking Status .11 .08 .19 .15 
    Step 3 
    
.26 .04 2.95 .09 
  IL-6 Change .45 .27 .22 .09         
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Figure 7. Association of stressor-evoked IL-6 response and CRP (Aim 1) 
 
The hypothesis that greater stressor-evoked IL-6 responses are positively associated with 
IMT was not supported (Aim 2). Stressor-evoked IL-6 change scores were not significantly 
associated with IMT in the minimally adjusted model (β = .13, p = .30) or the fully adjusted 
model (Table 5). Demographic variables (Step 1) accounted for 18% of the variance in IMT (ΔR2 
= .18, p = .007), with older age significantly associated with greater IMT (β = .43, p = .001). 
BMI and smoking status (Step 2) accounted for an additional 19% of the variance in IMT (ΔR2 = 
.19, p = .001), with BMI significantly associated with IMT (β = .43, p < .001). Stressor-evoked 
IL-6 change scores (Step 3) were not associated with IMT (β = .12, p = .29) (Figure 8).   
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Table 5. Aim 2: Linear regression predicting IMT with stressor-evoked IL-6 
  N = 62   
  B SE β p R2 ΔR2 ΔF Sig. ΔF 
Step 1 
    
.18 .18 4.41 .007 
  Age .01 .01 .43 .001 
      Sex -.01 .02 -.05 .72 
      Race  -.01 .02 -.05 .71 
    Step 2  
    
.37 .19 8.47 .001 
  BMI .01 .01 .43 <.001 
      Smoking Status -.02 .01 -.20 .08 
    Step 3 
    
.38 .01 1.14 .29 
  IL-6 Change .05 .04 .12 .29         
 
 
 
Figure 8. Association of stressor-evoked IL-6 response and IMT (Aim 2) 
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The hypothesis that greater stress-related HF-HRV suppression is associated with larger 
stressor-evoked IL-6 responses was not supported (Aim 3). Stressor-evoked HF-HRV 
suppression was not significantly associated with stressor-evoked IL-6 responses in the 
minimally adjusted model (β = -.10, p = .49) or the fully adjusted model (Table 6). None of the 
steps of the fully adjusted model explained significant variance in stressor-evoked IL-6 
responses, although sex was significantly associated with IL-6 change scores (β = .34, p = .02), 
such that females showed greater IL-6 change scores. Stressor-evoked HF-HRV suppression 
(Step 3) was not significantly associated with stressor-evoked IL-6 (β = .09, p = .52) (Figure 9).  
 
Table 6. Aim 3: Linear regression predicting stressor-evoked IL-6 with stressor-evoked HF-HRV 
  N = 57   
  B SE β p R2 ΔR2 ΔF Sig. ΔF 
Step 1 
    
.10 .10 2.05 .12 
  Age -.01 .01 -.11 .42 
      Sex .13 .05 .34 .02 
      Race  .01 .05 .01 .97 
    Step 2  
    
.11 .003 .08 .93 
  BMI .01 .01 .05 .73 
      Smoking Status -.01 .03 -.03 .84 
    Step 3 
    
.11 .01 .41 .52 
  IL-6 Change .03 .05 .09 .52         
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Figure 9. Association of stressor-evoked HF-HRV and stressor-evoked IL-6 response (Aim 3) 
The hypothesis that greater stressor-evoked HF-HRV suppression would be associated 
with higher resting levels of CRP was not supported (Aim 4). Stressor-evoked HF-HRV 
suppression was not significantly associated with CRP in the minimally adjusted model (β = -
.12, p = .31) or the fully adjusted model (Table 7). In the fully adjusted model, demographic 
variables (Step 1) did not account for significant variance in CRP. BMI and smoking status (Step 
2) accounted for 19% of the variance in CRP (ΔR2 = .19, p = .001), with higher BMI
significantly associated with higher CRP (β = .374, p = .001). Stressor-evoked HF-HRV 
suppression (Step 3) was not significantly associated with CRP (β = -.14, p = .22) (Figure 10).  
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Table 7. Aim 4: Linear regression predicting CRP with stressor-evoked HF-HRV 
N = 76 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Step 1 .04 .04 .86 .47 
  Age -.01 .01 -.02 .90 
  Sex .06 .10 .07 .54 
  Race .17 .11 .18 .13 
Step 2 .22 .17 8.34 .001 
  BMI .04 .01 .37 .001 
  Smoking Status .11 .06 .20 .07 
Step 3 .24 .02 1.57 .22 
  IL-6 Change -.10 .08 -.14 .22 
Figure 10. Association of stressor-evoked HF-HRV and CRP (Aim 4) 
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3.3.1 Respiration Adjustment of HF-HRV 
As respiration is known to have a significant influence on HF-HRV, controlling for respiratory 
parameters is recommended when using HF-HRV as a marker of PNS activity (Grossman, 
Karemaker, & Wieling, 1991). Since the repeated measures ANOVAs reported above indicate a 
significant main effect of the stressor-tasks on respiration rate, additional analyses were carried 
out to account for the possible confounding of respiration and HF-HRV. Respiration adjusted 
HF-HRV values were calculated by regressing HF-HRV values for each period onto respiration 
rate for the same period. A repeated measures ANOVA was carried out using the respiration 
adjusted HF-HRV values for Baseline, Incongruent, Congruent, and Recovery. There was no 
significant main effect of the stressor tasks on HF-HRV independent of respiration rate (F(3, 
252) = .00, p = 1.00, ηp  = .00). In other words, respiration rate accounts for all of the variation in
HF-HRV from Baseline to the Incongruent, Congruent, and Recovery periods. For this reason, 
primary regression analyses including HF-HRV (Aims 3 and 4) should be interpreted with 
caution. These analyses were re-run with the inclusion of residualized respiration rate change 
score as a covariate; the pattern of results remained the same. 
3.4 ANCILLARY ANALYSES 
There were significant sex differences in the magnitude of stressor-evoked IL-6 responses (F(1, 
60) = 4.85, p = .03, ηp  = .08) (Table 8). Specifically, females show a greater increase in IL-6
from Baseline to 30-min post-task compared with males (Figure 11). 
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Table 8. Mean IL-6 stratified by sex 
Baseline 30-min post task Raw Change N 
Males 1.21 (1.00) 1.31 (1.07) 0.10 42 
Females 1.23 (.75) 1.44 (.70) 0.21 20 
Overall 1.22 (.92) 1.36 (.96) 0.14 62 
Figure 11. Sex differences in stressor-evoked IL-6 responses (Ancillary Aim 1). 
The relationship between stressor-evoked IL-6 response and resting CRP varies by sex. 
There was a significant interaction between sex and stressor-evoked IL-6 responses in predicting 
CRP in the minimal model (β = -.36, p = .04) and the fully adjusted model (Table 9). In the fully 
adjusted model, covariates (Step 2) accounted for 21% of the variance in CRP (ΔR2 = .21, p 
= .01), with higher BMI significantly associated with higher CRP (β = .37, p = .006).  The sex  x
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IL-6 change interaction term (Step 3), accounted for 8% of the overall variance in CRP (ΔR2 
= .08, B = -1.33, β = -.39, p = .02). This indicates that the slope of the relationship between IL-6 
change and CRP differs by sex (Figure 12). In males, the slope of the association between 
stressor-evoked IL-6 change and CRP was 0.94; for every unit increase in IL-6 change, there is a 
0.94 increase in resting CRP. In females, the slope is -0.39; for every unit increase in IL-6 
change, there is a 0.39 unit decrease in resting CRP.6 Thus, the slope coefficient in males 
indicates the relationship predicted in Aim 1 of the primary analyses (greater stressor-evoked IL- 
6 responses are associated with higher levels of CRP). The slope coefficient in females indicates 
a negative association between stressor-evoked IL-6 response and resting CRP, such that greater 
stressor-evoked IL-6 responses are associated with lower resting CRP.  
6 Note that both stress-evoked IL-6 and resting CRP values used in regression analyses do not reflect the raw values 
of these variables and interpretation of slopes does not reflect raw units of these variables; IL-6 change scores are 
residualized scores accounting for baseline levels of IL-6, while the CRP values are log-10 transformed. 
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Table 9. Ancillary Aim 2: Linear regressions predicting CRP with stressor-evoked IL-6 x sex interaction 
N = 57 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Minimal Model 
   Step 1 .04 .04 1.16 .32 
     Sex -0.12 .12 -.14 .31 
     IL-6 Change 0.39 .29 .19 .18 
   Step 2  .12 .08 4.47 .04 
     Sex x IL-6 Change -1.23 .58 -.36 .04 
Fully Adjusted Model 
   Step 1 .04 .04 1.16 .32 
     Sex -0.12 .12 -.14 .31 
     IL-6 Change 0.39 .29 .19 .18 
   Step 2  .26 .21 3.60 .01 
     Age -0.01 .01 -.15 .26 
     Race 0.05 .11 .06 .64 
     BMI 0.03 .01 .37 .006 
     Smoking Status 0.12 .07 .21 .11 
   Step 3 .34 .08 6.11 .02 
     Sex x IL-6 Change -1.33 .54 -.39 .02 
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Figure 12. Sex specific associations of stressor-evoked IL-6 and CRP (Ancillary Aim 2). 
There was no evidence for an interaction between sex and stressor-evoked IL-6 response 
in predicting IMT. The sex x IL-6 change interaction term was not significantly associated with 
IMT in the minimal model (β = -.08, p = .63) or the fully adjusted model (Table 10; Figure 13). 
In the fully adjusted model, covariates (Step 2) accounted for 38% of the variance in IMT (ΔR2 = 
.38, p < .001), with greater IMT significantly associated with age (β = .35, p = .004) and BMI (β 
= .43, p <.001). The sex x IL-6 change interaction term (Step 3) was not significantly associated 
with IMT (β = -.04, p = .80). 
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Table 10. Ancillary Aim 2: Linear regressions predicting IMT with stressor-evoked IL-6 x sex interaction 
N = 62 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Minimal Model 
   Step 1 .02 .02 .71 .49 
     Sex 0.02 .02 .09 .49 
     IL-6 Change 0.04 .05 .10 .46 
   Step 2  .03 .01 .23 .63 
     Sex x IL-6 Change -0.05 .11 -.08 .63 
Fully Adjusted Model 
   Step 1 .02 .02 .71 .49 
     Sex 0.02 .02 .09 .49 
     IL-6 Change 0.04 .05 .10 .46 
   Step 2  .38 .36 8.05 <.001 
     Age 0.01 .001 .35 .004 
     Race -0.01 .02 -.02 .85 
     BMI 0.01 .002 .43 <.001 
     Smoking Status -0.02 .01 -.19 .09 
   Step 3 .39 .00 .06 .80 
     Sex x IL-6 Change -0.02 .09 -.04 .80 
41 
Figure 13. Sex specific associations of stressor-evoked IL-6 and IMT (Ancillary Aim 3). 
There was a significant main effect of the stressor tasks on both SBP (F(2.08, 181.21) = 
41.79, p <.001, ηp  = .32) and DBP (F(2.05, 178.03) = 16.32, p <.001, ηp  = .16) (Table 11). SBP 
increased significantly from Baseline to Incongruent (F(1, 87) = 81.49, p <.001, ηp  = .48) and 
Congruent (F(1, 87) = 72.55, p <.001, ηp  = .46); SBP levels remained significantly elevated 
during Recovery (F(1, 87) = 21.99, p <.001, , ηp  =.20). DBP also increased significantly from 
Baseline to Incongruent (F(1, 87) = 31.51, p <.001, ηp  = .27) and Congruent (F(1, 87) = 21.74, 
p <.001, ηp  = .20); these elevations remained marginally elevated from Baseline to Recovery 
(F(1, 87) = 3.70, p = .06, ηp  = .04). 
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There was no evidence for a significant association between IL-6 responses and either 
SBP or DBP (Table 12). In the minimally adjusted models, stressor-evoked SBP was not 
significantly associated with IL-6  (β = -.06, p = .63) nor was DBP (β = .18, p = .15). None of 
the steps of the fully adjusted model explained significant variance in stressor-evoked IL-6 
responses. Stressor-evoked SBP and DBP (Step 3) were not significantly associated with 
stressor-evoked IL-6 responses (SBP: β = -.07, p = .59; DBP: β = .18, p = .17) 
Table 11. Mean SBP and DBP across the testing session 
Baseline Incongruent Congruent Recovery 
SBP 111.08 116.26 115.82 113.71 
DBP 66.21 68.41 68.05 66.83 
Table 12. Ancillary Aim 4: Linear regressions predicting stressor-evoked IL-6 with SBP and DPB 
N = 62 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Step 1 .09 .09 1.98 .13 
  Age -0.01 .01 -.09 .49 
  Sex 0.11 .06 .28 .05 
  Race -0.05 .05 -.12 .37 
Step 2 .10 .002 .07 .94 
  BMI 0.00 .01 .01 .93 
  Smoking Status -0.01 .04 -.05 .72 
Step 3 (separate models) 
   SBP -0.01 .01 -.07 .59 .10 .005 .29 .60 
   DBP 0.01 .01 .18 .17 .13 .03 1.92 .17 
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4.0  DISCUSSION 
This study examined interrelationships between acute stressor-evoked inflammatory responses, 
CVD risk factors, and stressor-evoked psychophysiological responses. The stressor tasks elicited 
the expected responses: decreases in HF-HRV and increases in IL-6, HR, respiration, and BP. 
The interrelationships between these responses and CVD risk factors were explored with four 
primary aims. Aim 1 assessed whether the magnitude of acute stressor-evoked inflammatory 
responses positively associates with resting levels of systemic inflammation. Across all 
participants, results revealed no significant association of stressor-evoked IL-6 responses with 
circulating levels of CRP. However, ancillary analyses showed that sex moderated the magnitude 
of the association. Specifically, males showed a positive association between stressor-evoked IL-
6 responses and CRP while females showed a negative association. Aim 2 examined whether 
stressor-evoked IL-6 responses associate with preclinical atherosclerotic CVD risk, as measured 
by IMT. Here, results showed no significant association and that sex does not moderate the 
relationship. Aim 3 examined whether stressor-evoked decreases in HF-HRV, a marker of 
parasympathetic activity, associate with magnitude of IL-6 response following the task. Results 
did not show a significant association between task-related decreases in HF-HRV and increases 
in IL-6. Finally, in Aim 4, we examined whether stressor-evoked decreases in HF-HRV relate to 
circulating levels of systemic inflammation. Again, we observed no significant association 
between stressor-evoked HF-HRV and CRP.  Although our study hypotheses were largely 
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unsupported, below we consider a number of interpretive caveats and limitations that may clarify 
these results. 
4.1 AIM 1: STRESSOR-EVOKED IL-6 RESPONSES AND CRP 
Stressor-evoked IL-6 responses were not significantly associated with resting CRP when males 
and females were analyzed together. However, ancillary analyses revealed a significant 
interaction between sex and stressor-evoked IL-6 responses, such that males showed a positive 
association between magnitude of IL-6 responses and resting CRP while females showed a 
negative association. In addition, females showed greater stressor-evoked IL-6 responses 
compared with males, replicating previously reported sex differences in stressor-evoked IL-6 
responses (Hackett et al., 2012; Steptoe et al., 2002) 
Prior work suggests that there are sex differences in IL-6. Previous reports on resting 
levels of IL-6 have been mixed, with some studies finding higher levels in females (Chapman et 
al., 2009), others finding higher levels in males (Gruenewald, Seeman, Ryff, Karlamangla, & 
Singer, 2006; Thorand et al., 2006), and still others reporting no difference (Sadeghi, Daniel, 
Naujokat, Weimer, & Opelz, 2005). These reports suggest that sex differences in resting levels of 
IL-6 are inconsistent across samples. Prior work suggests that there may be more consistent sex 
differences in magnitude of stressor-evoked IL-6 responses. In the present study, females showed 
significantly larger stressor-evoked IL-6 responses than males. While two other laboratory stress 
studies found similar differences (Hackett et al., 2012; Steptoe et al., 2002), another found that 
males had higher levels of IL-6 than females at 30-min post-stress followed by a rapid decrease, 
while females showed higher levels at 60-min post-stress (Edwards et al., 2006). As both the 
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present study and the study by Steptoe and colleagues (2002) measured IL-6 only at 45-min post-
stressor, it is possible that this single post-stressor blood sample did not capture an earlier 
circulating IL-6 peak in males. However, this hypothesis is inconsistent with an additional report 
that females had higher levels of IL-6 immediately following the stressor task (Hackett et al., 
2012). In sum, although the exact pattern varies between studies, our findings support other 
reports that females show greater stressor-evoked IL-6 responses. 
The mechanisms underlying sex differences in stressor-evoked circulating IL-6 responses 
are not entirely clear. However, our mechanistic understanding may be informed by studies of 
sex differences in stimulated monocyte production of IL-6 in vitro. Although the in vitro work 
does show some parallels with our results, it should be noted that it is unclear whether responses 
to an immune stimulant are relevant for understanding variability in circulating levels of IL-6 in 
response to a psychological stressor. Considering that caveat, it does appear that females show 
larger stimulated IL-6 responses. One in vitro study found that lipopolysaccharide (LPS) 
stimulated IL-6 production is greater in females than in males (O'Connor, Motivala, Valladares, 
Olmstead, & Irwin, 2007). Another study assessed sex differences in stimulated IL-6 production 
30 minutes after an acute laboratory stress paradigm, finding that females showed greater IL-6 
production; however, these sex differences were only detected between males and post-
menopausal females (Prather et al., 2009). Thus, it is possible that females mount larger 
inflammatory responses to immune stimulants than males.  
A number of possible mechanisms may account for differential IL-6 response magnitude 
by sex. First, sex differences in HPA axis responses to stress may play a role. After stress 
exposure, GCs secreted by the HPA-axis inhibit IL-6 production (Argarwal et al., 1998; Miller, 
Cohen, & Ritchey, 2002).  A review of the literature on stressor-evoked cortisol responses 
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indicates that males show greater responses compared to females (Kudielka & Kirschbaum, 
2005). Thus, it is possible that enhanced cortisol responses in males may more effectively 
downregulate stressor-evoked IL-6 responses. However, in vitro studies show there are 
individual differences in the sensitivity of immune cells to GC signaling, leading to differences 
the ability of GCs to regulate inflammatory responses (Miller, Cohen, & Ritchey, 2002). 
Reductions in GC sensitivity are related to both chronic and acute stress exposure (Dickerson, 
Gable, Irwin, Aziz, & Kemeny, 2009; Miller et al., 2002). Notably, there is evidence for acute 
stressor-evoked sex differences in GC sensitivity. Specifically, one study found that males show 
acute stressor-evoked increases in GC sensitivity of IL-6 production while females showed no 
stressor-evoked changes (Rohleder, Schommer, Hellhammer, Engel, & Kirschbaum, 2001). This 
finding suggests that, after acute stress, GCs in females may be less effective in shutting down 
stimulated IL-6 responses. Thus, to the extent that stimulated IL-6 responses are related to 
stressor-evoked increases in circulating IL-6 levels, stressor-evoked differences in GC sensitivity 
may be one mechanism contributing to larger stressor-evoked IL-6 responses in females. 
Second, sex differences in IL-6 response magnitude may be explained by differences in 
autonomic activity. Support for this mechanistic explanation is mixed. A recent meta-analysis 
reported no sex differences in stressor-evoked PNS responses, but significantly greater stressor-
evoked SNS responses in males (Brindle et al., 2014). As greater SNS activation is thought to 
predict heightened inflammatory responses to stress, these meta-analytic results suggest that 
males should have larger IL-6 responses than females. Our data shows the opposite pattern, 
suggesting that sex differences in IL-6 response might not be driven by differential stressor-
evoked SNS activation. In addition to stressor-evoked autonomic responses, it has also been 
suggested that basal autonomic activity may account for sex differences in IL-6 responses. In a 
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one study, females showed both greater stimulated IL-6 production and a positive association 
between resting HF-HRV and stimulated IL-6 production, while males showed no association 
(O’Connor et al., 2007). The significant association in females runs contrary to the predictions of 
the cholinergic anti-inflammatory pathway (Tracey, 2002; 2009), which suggests that vagal 
activation should downregulate IL-6 production. Follow up analyses in the present study tested 
whether there were sex differences in the association between basal HF-HRV and stressor-
evoked IL-6 response. Analyses showed a marginally significant interaction, such that females 
show a negative association between resting HF-HRV and stressor-evoked IL-6 response while 
males show no association (ΔR2 = .05, β = -.25, p = .09). Taken together, these mixed findings 
are inconclusive and warrant continued exploration of sex differences in autonomic activity as a 
mechanism for sex differences in stressor-evoked IL-6 response. 
Third, it is possible that IL-6 expression is influenced by different levels of reproductive 
hormones, such as estrogens. In general, estrogens are thought to have an anti-inflammatory 
effect (Gubbels Bupp, 2015; Straub, 2007), inhibiting IL-6 production and gene expression (Liu, 
Liu, & Bodenner, 2005). Estrogen levels are generally lower in males compared with females, 
and lower in post-menopausal compared with pre-menopausal females (Darnall & Suarez, 2009; 
Gubbels Bupp, 2015). Thus, one would anticipate greater IL-6 production in post-menopausal 
females compared with males (Prather et al., 2009). Moreover, pre-menopausal females (i.e., 
those with the highest plasma concentrations of estrogens) should have the lower levels of IL-6 
production compared with males; however, this was not the case in the study by O’Connor et al. 
(2007). Additionally, females in the present sample were predominantly premenopausal (85.7%), 
and showed larger stressor-evoked IL-6 responses compared to males. To assess whether this 
small number of females influenced results, analyses were repeated excluding the post-
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menopausal females; without these participants all significant results remained significant. Thus, 
if estrogens do influence stressor-evoked IL-6 responses, their effect may not be simply anti-
inflammatory. In summary, the mechanisms that underlie sex differences in the magnitude of IL-
6 responses are not entirely clear, but interactions with the HPA axis, the ANS, and estrogens are 
likely involved. 
These same mechanisms may also be relevant to sex differences in the association 
between IL-6 responses and CRP. Exploratory analyses revealed that the relationship between 
stressor-evoked IL-6 responses and resting CRP differs by sex. It is surprising that, even though 
females showed larger stressor-evoked IL-6 responses, only males showed the hypothesized 
positive association between IL-6 responses and CRP. In males, our results support the 
assumption that larger acute stressor-evoked inflammatory responses are linked with greater 
resting levels of systemic inflammation. These results are consistent with previous work showing 
that larger stressor-evoked IL-6 responses are associated with other CVD risk factors (Brydon & 
Steptoe, 2005; Ellins et al., 2008). Importantly, these results are cross-sectional in nature and 
prevent us from making any claims about the direction of the relationship between stressor-
evoked IL-6 responses and CRP. As IL-6 is a precursor of CRP, it is plausible that, over time 
larger stressor-evoked IL-6 responses cause heightened systemic levels of CRP. Conversely, it is 
possible that heightened levels of systemic CRP may somehow prime immune cells to produce 
larger amounts of IL-6 in response to acute stress. Although it is impossible to answer such 
mechanistic questions with these data, future longitudinal work could help elucidate the temporal 
relationship between stressor-evoked IL-6 responses and resting systemic inflammation. Such 
work should consider that longitudinal associations may also differ by sex. 
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Unlike males, females showed a negative association between stressor-evoked IL-6 
responses and CRP. The reason for these sex differences is uncertain; demographics and 
biobehavioral characteristics (i.e., age, race, BMI, and smoking status) do not seem to explain the 
differential relationship. This pattern of sex differences is of particular interest, as CVD 
incidence rates in females show an approximate 10-year lag behind incidence in males (Gubbels 
Bupp, 2015; Lerner & Kannel, 1986; Roger, Go, & Lloyd-Jones, 2012). This lag is often 
attributed to hormonal changes that occur during and after menopause; this may be particularly 
important here, as the present sample includes predominantly premenopausal females. 
Premenopausal females may be protected against inflammatory atherosclerotic processes by 
higher estrogen levels, as higher concentrations of estrogens tend to have anti-inflammatory 
effects (Gubbels Bupp, 2015). Thus, it may be that even though females show greater acute 
stressor-evoked IL-6 responses, this may not result in greater resting levels of systemic 
inflammation (i.e., CRP) due to higher levels of anti-inflammatory estrogens.  
In interpreting these sex differences, it is important to emphasize the limitations of the 
present sample. Specifically, the Aim 1 subsample included 57 participants, only 19 of whom 
were females. This small group of females may not be representative of the broader population. 
However, we did not find any systematic differences between these females and the rest of our 
analytic sample. Regardless, the small sample size is a major limitation of the present work; 
future studies should test these questions in a larger, more generalizable sample.  
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4.2 AIM 2: STRESSOR-EVOKED IL-6 RESPONSES AND IMT 
Our results showed that there is no significant association between stressor-evoked IL-6 
responses and IMT; in contrast to Aim 1, there were no sex differences obscuring a potential 
relationship. These results are contrary to previous evidence that stressor-evoked IL-6 responses 
are associated with preclinical CVD risk factors (Brydon & Steptoe, 2005; Ellins et al., 2008). 
The explanation for the null relationship between stressor-evoked IL-6 responses and IMT is less 
clear. The lack of association may be due to the cross-sectional nature of this study; it is possible 
that stressor-evoked IL-6 responses are indeed related to IMT, but not until a future time point. 
Cross-sectional analyses assume that ongoing inflammatory processes have occurred over a long 
enough period for stressor-evoked IL-6 responses to influence atherosclerotic processes. It is 
possible that participants in the study are not old enough for stressor-evoked IL-6 responses to 
have had an effect on atherosclerotic processes or for endothelial injury to have occurred. 
However, IMT was specifically selected as a marker of preclinical atherosclerotic risk because 
the degree of thickness has been show to be predictive of CVD risk, even in younger, healthier 
adults; this reduces the likelihood that the age of participants plays a major role. These questions 
could be addressed with longitudinal assessment of atherosclerosis and other markers of CVD 
risk. It is also possible that atherosclerotic processes are not influenced by these small, stressor-
evoked increases in IL-6. The duration of these elevations in circulating IL-6 have yet to be 
conclusively determined; it is possible that circulating IL-6 levels return to baseline after only a 
few hours and do not have any lasting impact. Finally, the lack of significant association may be 
due to the small sample. A post-hoc power analysis showed that, with a subsample of 62, we did 
not achieve adequate power to detect the small effect size (ƒ2 = .02). A sample size of 240 would 
be required to detect such a small effect size.  
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4.3 AIMS 3 & 4: STRESSOR-EVOKED HF-HRV AND INFLAMMATION 
Aims 3 and 4 focused on possible parasympathetic regulation of systemic inflammation. The 
lack of association of HF-HRV responses with both baseline CRP and stressor-evoked IL-6 
responses is surprising and does not align with the regulatory parasympathetic mechanism 
proposed by the cholinergic anti-inflammatory pathway (Tracey, 2002; 2009). Also contrary to 
the cholinergic anti-inflammatory pathway and previously reported associations (Sloan et al., 
2007), we failed to find any significant correlations between Baseline HF-HRV and resting 
levels of inflammatory markers (i.e., Baseline IL-6, resting CRP). There are three primary 
implications of these null findings. First, it is possible that the PNS does not play a meaningful 
role in regulating either baseline or stressor-evoked levels of circulating inflammatory markers. 
If this is indeed the case, it may be that stressor-evoked inflammatory responses are primarily 
driven by the SNS and HPA-axis. This would align with previous work arguing that there is 
insufficient evidence for parasympathetic innervation of any primary immune organs (Nance and 
Sanders, 2007). Second, our in vivo methods of assessing inflammatory markers are markedly 
different from the in vitro evidence and animal models that support the cholinergic anti-
inflammatory pathway (Tracey, 2002; 2009). It may be that the PNS does regulate inflammatory 
cytokine production at the cellular level, but we are unable to detect such relationships using 
gross measurements of circulating inflammatory markers. Third, it may be that PNS activation is 
not accurately measured by HF-HRV. As previously noted, HF-HRV is a marker of PNS input to 
the heart and does not reflect system-wide PNS activation. Thus, it is possible that more direct 
and invasive measurements of stressor-evoked PNS activation would yield different results. 
The validity of HF-HRV as a marker of PNS activation during acute stress is also brought 
into question by our analyses of respiratory control of HF-HRV. Specifically, there was no 
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significant change in HF-HRV across the task periods after controlling for respiration rate. 
Respiratory control in HRV measurement has been strongly suggested by the 
psychophysiological literature (Berntson et al., 1997; Grossman, Karemaker, & Wieling, 1991). 
This suggestion was initially based on observational evidence that HF-HRV and RSA are highly 
correlated with respiratory parameters. The observational evidence is further supported by 
experimental evidence that RSA is generated by two different respiratory mechanisms: 1) central 
respiratory drive modulates the activity of cardiac vagal neurons and 2) lung inflation inhibits 
vagal input to the heart (Hayano & Yasuma, 2003; Horner, Brooks, Kozar, Gan, & Phillipson, 
1995). Based on this experimental evidence, it has been posited that RSA is an essential 
physiological mechanism of the cardiopulmonary system in resting animals that optimizes 
pulmonary gas exchange efficiency. Further, this optimization process may not be reflected by 
measures of RSA during stress or physical strain, as these conditions often evoke significant 
variations in respiratory parameters (Hayano & Yasuma, 2003; Yasuma & Hayano, 2004). 
Experimental evidence supports this assertion: when there is significant variation in stressor-
evoked respiration, RSA only reflects vagal input to the heart when respiratory parameters are 
experimentally or statistically controlled (Berntson et al., 1997; Grossman et al., 1991). For this 
reason, respiratory control of stressor-evoked HRV measures is thought to be particularly 
important (Berntson et al., 1997). Notably, it has also been argued that controlling for respiratory 
parameters is an overly conservative approach (Berntson et al., 1997; Horner et al., 1995).  
If controlling for respiratory parameters is indeed essential, our results indicate that there 
were no significant stressor-evoked changes in PNS input to the heart. This finding is somewhat 
at odds with work showing consistent stressor-evoked decreases in HF-HRV in a recent meta-
analysis (Brindle et al., 2014). However, this meta-analysis did not report whether the reviewed 
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studies corrected for respiratory parameters. This is not surprising, as many studies that utilize 
HF-HRV as a marker of PNS control of the heart do not measure or control for respiratory 
parameters. Our findings reiterate that stressor-evoked changes in HF-HRV are highly influenced 
by respiratory parameters. In addition, these findings raise questions about the validity of using 
HF-HRV change scores as a marker of stressor-evoked PNS change. Given these methodological 
issues, the null association of HF-HRV change scores with CRP and stressor-evoked IL-6 
responses reported here does not necessarily rule out PNS regulation of systemic inflammation. 
4.4 ANCILLARY ANALYSES: BP AND STRESSOR-EVOKED IL-6 
The ancillary BP analyses in this study also failed to elucidate whether the SNS drives stressor-
evoked IL-6 responses. Specifically, our results showed no significant association between 
stressor-evoked IL-6 responses and either SBP or DBP responses. These findings are contrary to 
mechanisms suggested by rodent and in vitro evidence (Bierhaus et al., 2003; Johnson et al., 
2005) and suggest that the SNS may not be the primary driver of the stressor-evoked IL-6 
response. However, there are several other possible explanations for this null result. First, BP 
was included as a crude indicator of stressor-evoked SNS activity, even though it also reflects 
some degree of PNS input. Future work exploring the underlying mechanisms of stressor-evoked 
IL-6 responses should employ a more specific psychophysiological indicator of SNS activity 
(i.e., pre-ejection period) (Cacioppo, Uchino, & Berntson, 1994). A second explanation for this 
null result is that there were significant methodological issues with the BP collection. Because 
the intravenous catheter was inserted in participants’ left arm for the duration of the laboratory 
protocol, BP measurements had to be taken from the right arm (i.e., the same arm used to 
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respond to the computerized stress tasks). For many participants, this did not significantly 
interfere with BP collection. For some participants, however, the small amount of movement 
needed to press buttons on the keyboard interfered with BP readings. This interference and 
previous evidence that motor activity can lead to increases in BP (Shapiro et al., 1996), suggests 
that our BP readings may not be entirely accurate. For these reasons, it is impossible to rule out 
SNS stimulation of stressor-evoked IL-6 responses. 
4.5 LIMITATIONS AND FUTURE DIRECTIONS 
There are a number of limitations to the current study design. Data collection for this study was 
largely cross-sectional, preventing any causal inferences about the relationships between study 
variables. Future work should explore these research questions using longitudinal assessments of 
CVD risk variables to better understand whether stressor-evoked IL-6 responses predict future 
CVD risk. In particular, longitudinal assessment of CRP would be very informative for 
determining whether the significant interaction between sex and stressor-evoked IL-6 responses 
can predict systemic inflammation over time. Such longitudinal work is imperative, as systemic 
inflammation predicts future CVD risk (Kaptoge et al., 2010; Libby & Ridker, 1999; van Holten 
et al., 2013). In addition, this study did not include a non-stress control group. Although a control 
group could strengthen these data, previous work has shown that IL-6 levels do not increase 
significantly over time in non-stress control participants (Steptoe et al., 2001). This study also 
did not assess stressor-evoked IL-6 responses on multiple occasions. Previous research indicates 
that stressor-evoked IL-6 responses do not habituate over repeated testing sessions (von Kanel et 
al., 2006) but may sensitize on exposure to repeated stressors (McInnis et al., 2014). Repeated 
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measurements of IL-6 responses on multiple occasions could clarify these issues and increase the 
reliability of individual differences in these responses.  
Mechanistic interpretations of these data are also limited by our method of measuring IL-
6. Levels of IL-6 were determined by assessing levels in the peripheral circulation. This is a 
highly nonspecific method that gives no indication of which cells in the body produced the IL-6. 
While our interpretations assume that stressor-evoked IL-6 is produced by immune cells, IL-6 is 
also produced by endothelial cells and adipocytes (Mohamed-Ali et al., 1997; Papanicolaou et 
al., 1998). Indeed, previous in vitro work indicates that human adipocytes treated with adrenergic 
agonists secrete IL-6 (Mohamed- Ali et al., 2001), suggesting that adipocytes may be an 
important source of stressor-evoked IL-6 increases. As it is not possible to test this question with 
the present data, our understanding of the source of stressor-evoked IL-6 responses is limited. 
The limitations of this sample should also be noted. First, this is a relatively healthy 
middle-aged sample, composed primarily of White and Black participants. Thus, these results 
may not generalize to disease populations or non-Black ethnic minorities. In addition, there were 
a number of participants with missing data in this sample; this was primarily due to the 30% of 
participants who were unable to provide both pre- and post-task blood samples for IL-6. These 
participants were not included in any of the IL-6 analyses but did not differ significantly from the 
rest of the sample on age, sex, or BMI. Finally, the relatively small sample may not have 
provided sufficient power to detect small effect sizes between study variables. Testing these 
questions with a larger sample could elucidate whether the nonsignificant findings reported here 
were due the small sample size or an actual null relationship between study variables.  
While many questions remain, this study can inform future work on the underlying 
mechanisms and CVD risk correlates of individual differences in stressor-evoked inflammatory 
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responses. Although it is still unclear whether stressor-evoked inflammatory responses predict 
future CVD risk, our results emphasize the importance of examining sex differences in these 
relationships. In particular, it seems that stressor-evoked IL-6 responses are larger in females, but 
may not show the expected positive associations with systemic inflammation. Finally, our 
findings did not support the hypothesis that PNS activity during stress predicts stressor-evoked 
inflammatory responses or systemic inflammation; however, our results emphasize the 
importance of respiratory control of HF-HRV. In conclusion, stressor-evoked inflammatory 
responses may have important implications for systemic inflammation, but additional work is 
needed to understand the underlying mechanisms of these responses and whether they can 
predict future CVD risk.   
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